Work

Macula densa-targeting gene delivery in vivo using AAV9

Year: 2026
Type: preprint
Abstract: Macula densa (MD) cells are key sensory and regulatory cells in the kidney; however, they have been difficult to study because of a lack of cell-specific, user-friendly in vivo research tools. Here we demonstrate the high affinity of wild-type Adeno-Associated Virus serotype 9 (AAV9) for MD cells and the feasibility of AAV9-mediated MD cell-specific genetic manipulations when administered to neonatal mice or after a temporary physiological challenge (low-salt diet) in the adult. A single intraperitoneal injection of low-dose AAV9-GFP given to neonatal mice on postnatal days P2-3 resulted in highly MD-specific and efficient transduction (∼85% of all GFP+ cells were Nos1+ MD cells). Proof-of-concept studies used AAV9 to overexpress or knock down biologically relevant genes in MD cells and establish MD gain- and loss-of-function (Gof/Lof) mouse models for initial functional and structural phenotyping using intravital multiphoton microscopy at the single-nephron level and immunofluorescence-based histological analysis. RNAscope confirmed the MD-specific knockdown of Pregnancy-associated plasma protein A2 (Pappa2) expression by AAV9-Pappa2 shRNA treatment in MD-Pappa2 Lof mice, and the MD- specific overexpression of Cell communication network 1 (Ccn1) by AAV9-Ccn1 mRNA treatment in MD-Ccn1 Gof mice. The mouse phenotypes revealed alterations in classic MD/juxtaglomerular functions (renin control and tubuloglomerular feedback-mediated glomerular hemodynamics) as well as in newly emerging MD cell functions (tissue remodeling). MD-specific genetic manipulations in vivo via AAV9-mediated gene delivery may enable future studies of MD cell functions, including the MD program for endogenous kidney tissue remodeling and regeneration, and support the development of MD cell-targeting gene therapies for kidney diseases. NEW & NOTEWORTHY The AAV9 gene delivery approach described in this study may be useful for straightforward in vivo genetic manipulation of the minority renal cell type, the macula densa (MD), in preclinical renal physiology and disease research. This novel research tool may improve our understanding of the classic renal hemodynamic and renin-regulatory functions of the understudied MD cells, as well as their newly emerging roles in kidney tissue remodeling and regeneration and in the renal nervous system. In the long term, AAV9-mediated MD targeting gene delivery may enable the development of gene therapies for a range of kidney diseases.
Language: English
Subfield: Genetics
Open Access status: green
OpenAlex ID: W7233888865
Cites: 34
Cited by:
Related to: 10